Glycerin

Glycerin

SCHEMBL888512

O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.OCC(O)CO

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Glycerin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.64
ALDH1A1 P00352 1/20 0.64
THRB P10828 2/20 0.42
GABRR1 P24046 1/20 0.36
GABBR2 O75899 1/20 0.36
GABBR1 Q9UBS5 1/20 0.36
KDM4E B2RXH2 1/20 0.33
MMP2 P08253 1/20 0.33
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 1/20 0.33
OR51E2 Q9H255 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
AKR1B1 P15121 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
MAPT P10636 1/20 0.32
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
ANPEP P15144 1/20 0.30
ERAP2 Q6P179 1/20 0.30
USP2 O75604 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycerin SCHEMBL30710214 1.00 LMNA (0.64) LMNAALDH1A1THRBGABRR1GABBR2
Glycerin SCHEMBL31106042 1.00 LMNA (0.64) LMNAALDH1A1THRBGABRR1GABBR2
Glycerin SCHEMBL579432 1.00 LMNA (0.64) LMNAALDH1A1THRBGABRR1GABBR2
Glycerin SCHEMBL188342 1.00 LMNA (0.64) LMNAALDH1A1THRBGABRR1GABBR2
Glycerin SCHEMBL21101 1.00 LMNA (0.64) LMNAALDH1A1THRBGABRR1GABBR2
Glycerin SCHEMBL468814 0.97 LMNA (0.60) LMNAALDH1A1THRBGABRR1GABBR2
Glycerin SCHEMBL1792712 0.97 LMNA (0.60) LMNAALDH1A1THRBGABRR1GABBR2
Glycerin SCHEMBL14482187 0.97 LMNA (0.60) LMNAALDH1A1THRBGABRR1GABBR2
Glycerin SCHEMBL14482185 0.97 LMNA (0.60) LMNAALDH1A1THRBGABRR1GABBR2
Glycerin SCHEMBL9332836 0.97 LMNA (0.60) LMNAALDH1A1THRBGABRR1GABBR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4692364-A1 METHOD FOR PRODUCING SUBSTANCE Mitsubishi Chemical Corporation (JP) 2026-02-11 EP claimed
US-20260028656-A1 METHOD FOR PRODUCING SUBSTANCE MITSUBISHI CHEMICAL CORPORATION (JP) 2026-01-29 US claimed
CN-119574538-A Blood fat test card based on photochemical principle and blood fat detection method 湖南宏怡生物科技有限公司 2025-03-07 CN claimed
CN-118620969-B Method for producing xylitol by hemicellulose hydrolysate two-stage biological method 浙江容锐科技有限公司 2025-03-04 CN claimed
CN-118726307-B Phospholipase A1 and method for integrating secretory expression in bacillus subtilis and application thereof 广西科学院 2025-02-18 CN claimed
WO-2024204694-A1 METHOD FOR PRODUCING SUBSTANCE 三菱ケミカル株式会社 2024-10-03 WO claimed
CN-118726307-A Phospholipase A1 and method for integrating secretory expression in bacillus subtilis and application thereof 广西科学院 2024-10-01 CN claimed
CN-118620969-A Method for producing xylitol by hemicellulose hydrolysate two-stage biological method 浙江容锐科技有限公司 2024-09-10 CN claimed
CN-118329995-A Preparation method of glycerase sensing chip 南京工业大学 2024-07-12 CN claimed
CN-113430127-B Recombinant bacterium for producing L-lactic acid and application thereof 江南大学 2024-01-12 CN claimed
CN-115259396-A Novel composite carbon source preparation system and preparation method 浙江瑞逸鑫环保科技有限公司 2022-11-01 CN claimed
CN-114636737-A Enzyme biosensor based on molybdenum disulfide quantum dots-reduced graphene oxide and preparation method and application thereof 华南理工大学 2022-06-17 CN claimed
CN-114636738-A Enzyme biosensor and preparation method and application thereof 华南理工大学 2022-06-17 CN claimed
CN-112444544-B Glycerol enzyme biosensor based on carboxylated nano zinc oxide and preparation method and application thereof 华南理工大学 2022-03-29 CN claimed
CN-113340832-A Method for detecting hydrogen peroxide and lactic acid based on colorimetric principle and application thereof 暨南大学 2021-09-03 CN claimed
CN-112553235-A Glycerol induction expression system and application thereof in natto kinase production 江南大学 2021-03-26 CN claimed
EP-0405988-B1 Use of superoxide dismutase in assays involving an oxidase SANKYO CO (JP) 1996-03-27 EP claimed
WO-1993023054-A1 POLYPHOSPHORYLATED ORGANIC COMPOUNDS: COMPOSITIONS USEFUL IN PROTECTING BIOLOGICAL TISSUES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1993-11-25 WO claimed
US-5260287-A Phosphorylated alcohols and polyvalent cations used as antiulcer agents BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 1993-11-09 US claimed
EP-0405988-A2 Use of superoxide dismutase in assays involving an oxidase Sankyo Company Limited (JP) 1991-01-02 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028656-A1 METHOD FOR PRODUCING SUBSTANCE NADK, NAMPT, PRPS1 LMNA 4302/4885ALDH1A1 1254/4885THRB 1542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.